IDEXX is trading at $539.01, +4.11% versus the October 1 close, with no clearly verified company-specific announcement on October 2 explaining the pre-market move. - The latest company release set third-quarter results for November 2. - IDEXX’s CoVetAI acquisition was announced September 16, not a fresh October 2 catalyst. - U.S. futures and major indexes are higher, while the supplied healthcare-sector trend is lower; available evidence does not establish a direct cause for IDEXX’s gain.